Erectile dysfunction in men treated for testicular cancer

Authors:

Abstract
Objective: To study the unique characteristics of erectile dysfunction ( ED ) in a population of men who developed ED after testicular cancer ( TC ) diagnosis and treatment. Patients and Methods: All men treated for TC who presented for sexual function evaluation were included in an institutional database. All men underwent standard evaluation including a history/physical examination, completion of the I nternational I ndex of E rectile F unction ( IIEF ) questionnaire, testosterone/gonadotropin measurement and penile duplex D oppler ultrasonography ( DUS ). Results: The study population comprised 76 men whose mean ( sd ) age was 29 (8) years and of whom 25% were married/had a partner. In all, 39% of the patients had seminoma and 61% had non‐seminomatous germ‐cell tumour ( NSGCT ). A total of 66% of patients with seminoma underwent radiation therapy. Of the patients with NSGCT , 79% received chemotherapy, 18% underwent primary retroperitoneal lymph node dissection ( RPLND ) and 20% underwent post‐chemotherapy RPLND . The mean ( sd ) time before seeking sexual medicine consultation was 12 (7) months after treatment completion, the median (range) number of vascular risk factors was 0 (0–2) and the mean ( sd ) remaining testis volume was 16 (8) mL. Mean ( sd ) total testosterone, luteinizing hormone, follicle‐stimulating hormone levels were 312 (186) ng/dL, 9 (7) IU/mL, 17 (12) IU/mL. A total of 26% of patients had total testosterone levels <300 ng/dL. In all, 84% of patients complained primarily of loss of erection‐sustaining capability and 24% had episodes of transient ED before TC diagnosis. The mean ( sd ) IIEF erectile function domain score was 16 (7). All the patients (100%) had a normal DUS . Mean ( sd ) peak systolic and end‐diastolic velocities were 48 (16) and 1.2 (2.2) cm/s, respectively. A total of 88% of patients responded to phosphodiesterase type 5 inhibitor ( PDE 5i) use with erections sufficient for penetration, but 12% did not (mean [ sd ] erectile function domain score 27 [5] vs 17 [6]). There were no differences in haemodynamics between those men with and without hypogonadism. Conclusions: Men with TC presenting with ED after treatment appear uniformly to have normal erectile haemodynamics, suggesting adrenaline‐mediated ED . While the majority of TC survivors with ED respond successfully to PDE 5i, a significant minority do not.

This publication has 11 references indexed in Scilit: